Who owns BRAINSTORM CELL THERAPEUTICS?

Tip: Access positions for across all investors

Analyze quarterly positions in Brainstorm Cell Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Brainstorm Cell Therapeutics stock

Who bought or sold BRAINSTORM CELL THERAPEUTICS this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Abner, Herrman & BrocK 146k $34k 100% Sep 2024
 View chart
D. J. St. Germain 500.00 $115.000000 100% Sep 2024
 View chart
Bogart Wealth 34.00 $8.000200 100% Sep 2024
 View chart